首页> 外国专利> -CD46 MACROPINOCYTOSING HUMAN ANTI-CD46 ANTIBODIES AND TARGETED CANCER THERAPEUTICS

-CD46 MACROPINOCYTOSING HUMAN ANTI-CD46 ANTIBODIES AND TARGETED CANCER THERAPEUTICS

机译:-CD46宏细胞凋亡抗人类CD46抗体和靶向癌症治疗

摘要

In various embodiments, antibody-CD46 antibodies that are internalized into and enter the tumor cells through the ocular cell pathway, as well as antibody-CD46 antibodies developed from these antibodies for diagnostic and / or therapeutic targeting of CD46 overexpressing tumors, Drug conjugates (ADCs) are also provided.
机译:在各种实施方案中,通过眼细胞途径内化并进入肿瘤细胞的抗体-CD46抗体,以及从这些抗体开发的用于诊断和/或治疗性靶向CD46过表达的肿瘤的抗体-CD46抗体,药物缀合物(ADC) )。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号